Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Amneal has acquired Kashiv BioSciences, a pharmacy business in the healthcare sector in New Jersey. Kashiv BioSciences supports drug development and pharmaceutical supply activities that complement Amneal’s branded and generic portfolio. Amneal acquisitions in pharmacy strengthen its capabilities across healthcare M&A and expand access to additional product opportunities. The add on acquisition is announced and structured as a strategic acquisition, with deal size undisclosed and terms not publicly specified.
Source
Read full article on businesswire.comvia GN - entered into definitive agreement · April 23, 2026
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026